368 related articles for article (PubMed ID: 21248121)
1. Axonal degeneration is mediated by the mitochondrial permeability transition pore.
Barrientos SA; Martinez NW; Yoo S; Jara JS; Zamorano S; Hetz C; Twiss JL; Alvarez J; Court FA
J Neurosci; 2011 Jan; 31(3):966-78. PubMed ID: 21248121
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
[TBL] [Abstract][Full Text] [Related]
3. Axonal Degeneration Is Mediated by Necroptosis Activation.
Arrázola MS; Saquel C; Catalán RJ; Barrientos SA; Hernandez DE; Martínez NW; Catenaccio A; Court FA
J Neurosci; 2019 May; 39(20):3832-3844. PubMed ID: 30850513
[TBL] [Abstract][Full Text] [Related]
4. The P66Shc/mitochondrial permeability transition pore pathway determines neurodegeneration.
Savino C; Pelicci P; Giorgio M
Oxid Med Cell Longev; 2013; 2013():719407. PubMed ID: 23766859
[TBL] [Abstract][Full Text] [Related]
5. Diapause formation and downregulation of insulin-like signaling via DAF-16/FOXO delays axonal degeneration and neuronal loss.
Calixto A; Jara JS; Court FA
PLoS Genet; 2012; 8(12):e1003141. PubMed ID: 23300463
[TBL] [Abstract][Full Text] [Related]
6. MEC17-induced α-tubulin acetylation restores mitochondrial transport function and alleviates axonal injury after intracerebral hemorrhage in mice.
Yang Y; Chen X; Feng Z; Cai X; Zhu X; Cao M; Yang L; Chen Y; Wang Y; Feng H
J Neurochem; 2022 Jan; 160(1):51-63. PubMed ID: 34407220
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.
Rao VK; Carlson EA; Yan SS
Biochim Biophys Acta; 2014 Aug; 1842(8):1267-72. PubMed ID: 24055979
[TBL] [Abstract][Full Text] [Related]
8. Chronic ethanol consumption enhances sensitivity to Ca(2+)-mediated opening of the mitochondrial permeability transition pore and increases cyclophilin D in liver.
King AL; Swain TM; Dickinson DA; Lesort MJ; Bailey SM
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G954-66. PubMed ID: 20651005
[TBL] [Abstract][Full Text] [Related]
9. Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis.
Warne J; Pryce G; Hill JM; Shi X; Lennerås F; Puentes F; Kip M; Hilditch L; Walker P; Simone MI; Chan AW; Towers GJ; Coker AR; Duchen MR; Szabadkai G; Baker D; Selwood DL
J Biol Chem; 2016 Feb; 291(9):4356-73. PubMed ID: 26679998
[TBL] [Abstract][Full Text] [Related]
10. Calcium release from intra-axonal endoplasmic reticulum leads to axon degeneration through mitochondrial dysfunction.
Villegas R; Martinez NW; Lillo J; Pihan P; Hernandez D; Twiss JL; Court FA
J Neurosci; 2014 May; 34(21):7179-89. PubMed ID: 24849352
[TBL] [Abstract][Full Text] [Related]
11. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore.
Nguyen TT; Stevens MV; Kohr M; Steenbergen C; Sack MN; Murphy E
J Biol Chem; 2011 Nov; 286(46):40184-92. PubMed ID: 21930693
[TBL] [Abstract][Full Text] [Related]
12. Not all mitochondrial carrier proteins support permeability transition pore formation: no involvement of uncoupling protein 1.
Crichton PG; Parker N; Vidal-Puig AJ; Brand MD
Biosci Rep; 2009 Dec; 30(3):187-92. PubMed ID: 19622065
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation.
Martin LJ; Adams NA; Pan Y; Price A; Wong M
J Neurosci; 2011 Jan; 31(1):359-70. PubMed ID: 21209222
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.
Du H; Yan SS
Biochim Biophys Acta; 2010 Jan; 1802(1):198-204. PubMed ID: 19616093
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria as a central sensor for axonal degenerative stimuli.
Court FA; Coleman MP
Trends Neurosci; 2012 Jun; 35(6):364-72. PubMed ID: 22578891
[TBL] [Abstract][Full Text] [Related]
16. Traumatic brain injury-induced axonal phenotypes react differently to treatment.
Hånell A; Greer JE; McGinn MJ; Povlishock JT
Acta Neuropathol; 2015 Feb; 129(2):317-32. PubMed ID: 25528329
[TBL] [Abstract][Full Text] [Related]
17. An approach to experimental synaptic pathology using green fluorescent protein-transgenic mice and gene knockout mice to show mitochondrial permeability transition pore-driven excitotoxicity in interneurons and motoneurons.
Martin LJ
Toxicol Pathol; 2011 Jan; 39(1):220-33. PubMed ID: 21378209
[TBL] [Abstract][Full Text] [Related]
18. HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart.
Lam CK; Zhao W; Liu GS; Cai WF; Gardner G; Adly G; Kranias EG
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6466-75. PubMed ID: 26553996
[TBL] [Abstract][Full Text] [Related]
19. Axonal degeneration induced by glutamate excitotoxicity is mediated by necroptosis.
Hernández DE; Salvadores NA; Moya-Alvarado G; Catalán RJ; Bronfman FC; Court FA
J Cell Sci; 2018 Nov; 131(22):. PubMed ID: 30333135
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.
Thomas B; Banerjee R; Starkova NN; Zhang SF; Calingasan NY; Yang L; Wille E; Lorenzo BJ; Ho DJ; Beal MF; Starkov A
Antioxid Redox Signal; 2012 May; 16(9):855-68. PubMed ID: 21529244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
